DETAILS, FICTION AND MODAFINIL NORGE

No unique dose adjustment advisable when tofacitinib coadministered with potent CYP2C19 inhibitors; minimize tofacitinib dose if coadministered with each moderate CYP3A4 and powerful CYP2C19 inhibitors .Effect of coadministration of a twin CYP3A4 and CYP2C19 inhibitor with fedratinib has not been analyzed.Modafinil was not noticed to advertise over